7OUK
BDM88855 inhibitor bound to the transmembrane domain of AcrB
7OUK の概要
| エントリーDOI | 10.2210/pdb7ouk/pdb |
| 分子名称 | Multidrug efflux pump subunit AcrB, (2S)-3-hydroxypropane-1,2-diyl didecanoate, DECYLAMINE-N,N-DIMETHYL-N-OXIDE, ... (14 entities in total) |
| 機能のキーワード | multidrug efflux pump, membrane protein, transport protein |
| 由来する生物種 | Escherichia coli 詳細 |
| タンパク質・核酸の鎖数 | 5 |
| 化学式量合計 | 389723.24 |
| 構造登録者 | |
| 主引用文献 | Ple, C.,Tam, H.K.,Vieira Da Cruz, A.,Compagne, N.,Jimenez-Castellanos, J.C.,Muller, R.T.,Pradel, E.,Foong, W.E.,Malloci, G.,Ballee, A.,Kirchner, M.A.,Moshfegh, P.,Herledan, A.,Herrmann, A.,Deprez, B.,Willand, N.,Vargiu, A.V.,Pos, K.M.,Flipo, M.,Hartkoorn, R.C. Pyridylpiperazine-based allosteric inhibitors of RND-type multidrug efflux pumps. Nat Commun, 13:115-115, 2022 Cited by PubMed Abstract: Efflux transporters of the RND family confer resistance to multiple antibiotics in Gram-negative bacteria. Here, we identify and chemically optimize pyridylpiperazine-based compounds that potentiate antibiotic activity in E. coli through inhibition of its primary RND transporter, AcrAB-TolC. Characterisation of resistant E. coli mutants and structural biology analyses indicate that the compounds bind to a unique site on the transmembrane domain of the AcrB L protomer, lined by key catalytic residues involved in proton relay. Molecular dynamics simulations suggest that the inhibitors access this binding pocket from the cytoplasm via a channel exclusively present in the AcrB L protomer. Thus, our work unveils a class of allosteric efflux-pump inhibitors that likely act by preventing the functional catalytic cycle of the RND pump. PubMed: 35013254DOI: 10.1038/s41467-021-27726-2 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (2.6 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






